Publication | Closed Access

Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling

InflammationFibrosisAntifibrotic TherapyInflammatory Lung DiseaseAllergyLung InflammationSilica-induced Pulmonary FibrosisImmunologyPathologyPulmonary PharmacologyPulmonary FibrosisNrf2-mediated InhibitionMedicineCell SignalingPulmonary DiseaseTgf-β1/smad Signaling